Anavex Life Sciences (AVXL) Tops Q1 EPS by 2c

Anavex Life Sciences (NASDAQ: AVXL) reported Q1 EPS of ($0.17), $0.02 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Anavex Life Sciences (AVXL) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Qtrex Quantum executives plan to buy up to 2M shares over 12 months
• AeroVironment restates quarterly financials, citing $89M goodwill error